VIEWRAY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000138 USD | +13,700.00% |
|
0.00% | 0.00% |
| Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
| Mar. 12 | Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products | MT |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 625.5 | 581.1 | 594.8 | 567.3 | 974.6 | 812.7 |
| Enterprise Value (EV) 1 | 612.6 | 469 | 436.3 | 478.6 | 824.2 | 763.2 |
| P/E ratio | -7.5 x | -6.22 x | -3.58 x | -5.24 x | -8.24 x | -7.54 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 18.4 x | 7.18 x | 6.78 x | 9.95 x | 13.9 x | 7.95 x |
| EV / Revenue | 18 x | 5.79 x | 4.97 x | 8.39 x | 11.8 x | 7.47 x |
| EV / EBITDA | -13.3 x | -7.05 x | -4.03 x | -4.81 x | -8.45 x | -7.61 x |
| EV / FCF | -12.1 x | -6 x | -14.7 x | -17.4 x | -41.3 x | -15.7 x |
| FCF Yield | -8.25% | -16.7% | -6.81% | -5.75% | -2.42% | -6.39% |
| Price to Book | 315 x | 3.49 x | 2.87 x | 4.36 x | 5.82 x | 9.89 x |
| Nbr of stocks (in thousands) | 67,544 | 95,730 | 140,956 | 148,500 | 176,882 | 181,416 |
| Reference price 2 | 9.260 | 6.070 | 4.220 | 3.820 | 5.510 | 4.480 |
| Announcement Date | 3/12/18 | 3/15/19 | 3/12/20 | 3/5/21 | 2/25/22 | 2/28/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 34.04 | 80.96 | 87.78 | 57.02 | 70.12 | 102.2 |
| EBITDA 1 | -45.93 | -66.56 | -108.2 | -99.5 | -97.56 | -100.3 |
| EBIT 1 | -48.16 | -70.09 | -112.9 | -106 | -103.6 | -105.3 |
| Operating Margin | -141.48% | -86.57% | -128.61% | -185.87% | -147.82% | -103.04% |
| Earnings before Tax (EBT) 1 | -72.18 | -76.4 | -120.2 | -107.9 | -110 | -107.3 |
| Net income 1 | -72.18 | -76.4 | -120.2 | -107.9 | -110 | -107.3 |
| Net margin | -212.02% | -94.36% | -136.93% | -189.26% | -156.94% | -105.01% |
| EPS 2 | -1.235 | -0.9754 | -1.178 | -0.7296 | -0.6689 | -0.5940 |
| Free Cash Flow 1 | -50.52 | -78.23 | -29.7 | -27.52 | -19.97 | -48.76 |
| FCF margin | -148.41% | -96.63% | -33.84% | -48.27% | -28.48% | -47.71% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/12/18 | 3/15/19 | 3/12/20 | 3/5/21 | 2/25/22 | 2/28/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 18.46 | 15.52 | 15.03 | 19.18 | 20.39 | 18.88 | 22.15 | 26.49 | 34.69 | 22.53 |
| EBITDA 1 | -23.29 | -23.03 | -24.96 | -21.82 | -27.86 | -26.23 | -28.39 | -22.78 | -24.8 | -28.67 |
| EBIT 1 | -25.34 | -24.68 | -26.48 | -23.29 | -29.2 | -27.47 | -29.79 | -23.92 | -25.95 | -29.63 |
| Operating Margin | -137.29% | -158.94% | -176.21% | -121.45% | -143.22% | -145.55% | -134.5% | -90.28% | -74.79% | -131.49% |
| Earnings before Tax (EBT) 1 | -26.1 | -26.74 | -30.98 | -25.26 | -27.07 | -25.77 | -27.63 | -26.11 | -27.82 | -28.86 |
| Net income 1 | -26.1 | -26.74 | -30.98 | -25.26 | -27.07 | -25.77 | -27.63 | -26.11 | -27.82 | -28.86 |
| Net margin | -141.4% | -172.26% | -206.09% | -131.73% | -132.77% | -136.54% | -124.76% | -98.55% | -80.18% | -128.07% |
| EPS 2 | -0.1800 | -0.1700 | -0.1900 | -0.1500 | -0.1600 | -0.1400 | -0.1500 | -0.1400 | -0.1500 | -0.1600 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/4/21 | 5/7/21 | 8/5/21 | 11/5/21 | 2/24/22 | 5/5/22 | 8/2/22 | 11/1/22 | 2/27/23 | 5/11/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 12.9 | 112 | 158 | 88.6 | 150 | 49.6 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -50.5 | -78.2 | -29.7 | -27.5 | -20 | -48.8 |
| ROE (net income / shareholders' equity) | 346% | -90.3% | -62.7% | -62.3% | -73.4% | -85.2% |
| ROA (Net income/ Total Assets) | -32.6% | -20.3% | -21.9% | -21.7% | -22.2% | -22.2% |
| Assets 1 | 221.2 | 375.5 | 549.4 | 498.2 | 495.5 | 483.7 |
| Book Value Per Share 2 | 0.0300 | 1.740 | 1.470 | 0.8800 | 0.9500 | 0.4500 |
| Cash Flow per Share 2 | 0.8500 | 1.740 | 1.540 | 1.050 | 1.220 | 0.7500 |
| Capex 1 | 2.16 | 3.69 | 7.76 | 6.18 | 1.56 | 3.9 |
| Capex / Sales | 6.35% | 4.55% | 8.84% | 10.84% | 2.22% | 3.81% |
| Announcement Date | 3/12/18 | 3/15/19 | 3/12/20 | 3/5/21 | 2/25/22 | 2/28/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 25.31K | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- VRAYQ Stock
- Financials ViewRay, Inc.
